Close
ACHEMA MIDDLE EAST 2026

First Gene Treatment For Early Bladder Cancer Okayed By FDA

The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or without papillary tumours has...

Hemophilia Gene Therapy Now Backed By European Regulators

The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy for haemophilia, a combo...

WHO Revises Treatment Recommendations For Drug-Resistant TB

The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements in the treatment options...

By 2032, The Alzheimers Treatments Market Will Be $6.8 Bn

The global Alzheimer's therapeutics market is anticipated to develop at a compound annual growth rate (CAGR) of 9.3% and reach $6.8 billion by 2032, according...

The Pharmaceutical Market In 2023- Trends And Predictions

The pharmaceutical sector has grown quickly in recent years, and by 2023 it is anticipated to reach USD 1.5 trillion. With the use of...

Quality Assurance Advances In Pharmaceutical Manufacturing

The needs of manufacturing facilities, tools, and procedures must be suitable for this new environment as the focus of new drug research shifts toward...

6 Issues In Pharma-Biotech Patent Disputes To Watch In 2023

Who will file a lawsuit under the UPC first? The deadline for opting out of patents will begin on March 1, 2023, and the UPC...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...